Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau

A vaccine trial that has been criticized for withholding hepatitis B vaccines from thousands of newborns in Guinea-Bissau has been given the green light to proceed. This trial aligns with the views of Robert F Kennedy Jr, a prominent vaccine critic, who has advocated for a different approach to vaccine distribution. The implications of this trial are significant, as it could potentially impact public health policies and vaccine regulations worldwide.

Why it matters

A controversial vaccine trial is raising concerns about the safety and efficacy of vaccines. This could lead to a decrease in public trust and demand for vaccines, ultimately affecting the stock prices of vaccine manufacturers.

Market impact

Markets & countries in focus

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to The Guardian. For information only — not financial advice.